Efi Makdasi

779 total citations
27 papers, 299 citations indexed

About

Efi Makdasi is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Efi Makdasi has authored 27 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Efi Makdasi's work include SARS-CoV-2 and COVID-19 Research (10 papers), Animal Virus Infections Studies (4 papers) and Bacillus and Francisella bacterial research (4 papers). Efi Makdasi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Animal Virus Infections Studies (4 papers) and Bacillus and Francisella bacterial research (4 papers). Efi Makdasi collaborates with scholars based in Israel and United States. Efi Makdasi's co-authors include Ronit Rosenfeld, Nir Paran, Yfat Yahalom-Ronen, Erez Bar‐Haim, Hadas Tamir, Ofer Cohen, Ron Alcalay, Uri Elia, Gonna Somu Naidu and Dan Peer and has published in prestigious journals such as Nature Communications, Nano Letters and ACS Nano.

In The Last Decade

Efi Makdasi

27 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Efi Makdasi Israel 9 143 127 90 60 31 27 299
Benedikt Asbach Germany 11 190 1.3× 132 1.0× 75 0.8× 77 1.3× 29 0.9× 28 373
Christopher L. D. McMillan Australia 11 134 0.9× 204 1.6× 83 0.9× 68 1.1× 16 0.5× 20 380
Lisa Shirreff United States 5 122 0.9× 105 0.8× 93 1.0× 50 0.8× 17 0.5× 5 251
Sarah A. Clark United States 8 212 1.5× 172 1.4× 49 0.5× 34 0.6× 52 1.7× 11 398
Enyue Fang China 6 249 1.7× 185 1.5× 90 1.0× 48 0.8× 18 0.6× 9 427
Christoph Kreer Germany 12 162 1.1× 218 1.7× 208 2.3× 68 1.1× 65 2.1× 17 500
Emily Gage United States 10 156 1.1× 111 0.9× 180 2.0× 70 1.2× 13 0.4× 11 343
Matthias Zehner Germany 11 159 1.1× 141 1.1× 241 2.7× 71 1.2× 53 1.7× 15 453
Maria T. Arévalo United States 13 104 0.7× 99 0.8× 72 0.8× 105 1.8× 10 0.3× 20 308
Nino Rcheulishvili China 12 225 1.6× 65 0.5× 77 0.9× 72 1.2× 18 0.6× 29 398

Countries citing papers authored by Efi Makdasi

Since Specialization
Citations

This map shows the geographic impact of Efi Makdasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efi Makdasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efi Makdasi more than expected).

Fields of papers citing papers by Efi Makdasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efi Makdasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efi Makdasi. The network helps show where Efi Makdasi may publish in the future.

Co-authorship network of co-authors of Efi Makdasi

This figure shows the co-authorship network connecting the top 25 collaborators of Efi Makdasi. A scholar is included among the top collaborators of Efi Makdasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efi Makdasi. Efi Makdasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenfeld, Ronit, Ron Alcalay, Sharon Melamed, et al.. (2025). Efficient Identification of Monoclonal Antibodies Against Rift Valley Fever Virus Using High-Throughput Single Lymphocyte Transcriptomics of Immunized Mice. Antibodies. 14(1). 12–12. 1 indexed citations
2.
Tamir, Hadas, Tal Noy-Porat, Sharon Melamed, et al.. (2024). Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection. Nature Communications. 15(1). 3265–3265. 10 indexed citations
3.
Noy-Porat, Tal, Hadas Tamir, Ron Alcalay, et al.. (2023). Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization. Microbiology Spectrum. 11(5). e0159823–e0159823. 7 indexed citations
4.
Levy, Yinon, Ron Alcalay, Anat Zvi, et al.. (2022). Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses. Vaccines. 10(2). 251–251. 4 indexed citations
5.
Makdasi, Efi, David Gur, Itai Glinert, et al.. (2022). Iron-Modified Blood Culture Media Allow for the Rapid Diagnosis and Isolation of the Slow-Growing Pathogen Francisella tularensis. Microbiology Spectrum. 10(5). e0241522–e0241522. 1 indexed citations
6.
Makdasi, Efi, David Gur, Ayelet Zauberman, et al.. (2022). An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen Yersinia pestis. Pathogens. 11(2). 255–255. 3 indexed citations
7.
Rosenfeld, Ronit, Ron Alcalay, Anat Zvi, et al.. (2022). Centaur antibodies: Engineered chimeric equine-human recombinant antibodies. Frontiers in Immunology. 13. 942317–942317. 4 indexed citations
8.
Bar‐On, Liat, Moshe Aftalion, Efi Makdasi, et al.. (2022). Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice. Vaccines. 10(4). 613–613. 1 indexed citations
9.
Milrot, Elad, Efi Makdasi, Amir Ben‐Shmuel, et al.. (2022). Development of an immunofluorescence assay for detection of SARS-CoV-2. Archives of Virology. 167(4). 1041–1049. 1 indexed citations
10.
Elia, Uri, Srinivas Ramishetti, Ronit Rosenfeld, et al.. (2021). Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles. ACS Nano. 15(6). 9627–9637. 84 indexed citations
11.
Noy-Porat, Tal, Ron Alcalay, Adva Mechaly, et al.. (2021). Characterization of antibody-antigen interactions using biolayer interferometry. STAR Protocols. 2(4). 100836–100836. 17 indexed citations
12.
Achdout, Hagit, Einat B. Vitner, Boaz Politi, et al.. (2021). Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity. Nature Communications. 12(1). 5819–5819. 50 indexed citations
13.
Makdasi, Efi, Yinon Levy, Ron Alcalay, et al.. (2021). Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope. Viruses. 13(4). 566–566. 20 indexed citations
14.
Israeli, Ofir, Efi Makdasi, Inbar Cohen-Gihon, et al.. (2020). A Rapid high-throughput sequencing-based Approach for the Identification of Unknown Bacterial Pathogens in Whole Blood. Future Science OA. 6(6). FSO476–FSO476. 9 indexed citations
15.
Makdasi, Efi, Tatyana B. Prigozhina, Yosi Gozlan, et al.. (2019). Toxicology and Pharmacokinetic Studies in Mice and Nonhuman Primates of the Nontoxic, Efficient, Targeted Hexameric FasL: CTLA4-FasL. Molecular Cancer Therapeutics. 19(2). 513–524. 3 indexed citations
16.
Makdasi, Efi, et al.. (2019). Whole-Cell Multiparameter Assay for Ricin and Abrin Activity-Based Digital Holographic Microscopy. Toxins. 11(3). 174–174. 13 indexed citations
17.
Prigozhina, Tatyana B., et al.. (2017). Fn14·TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog. Cancer Letters. 400. 99–109. 15 indexed citations
18.
Makdasi, Efi & Dan Eilat. (2013). L Chain Allelic Inclusion Does Not Increase Autoreactivity in Lupus-Prone New Zealand Black/New Zealand White Mice. The Journal of Immunology. 190(4). 1472–1480. 7 indexed citations
19.
Makdasi, Efi, et al.. (2009). Autoreactive Anti-DNA Transgenic B Cells in Lupus-Prone New Zealand Black/New Zealand White Mice Show Near Perfect L Chain Allelic Exclusion. The Journal of Immunology. 182(10). 6143–6148. 5 indexed citations
20.
Makdasi, Efi, et al.. (2009). B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice. International Immunology. 22(2). 101–111. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benedikt Asbach Breakdown of academic impact, for papers by Christopher L. D. McMillan Breakdown of academic impact, for papers by Lisa Shirreff Breakdown of academic impact, for papers by Sarah A. Clark Breakdown of academic impact, for papers by Enyue Fang Breakdown of academic impact, for papers by Christoph Kreer Breakdown of academic impact, for papers by Emily Gage Breakdown of academic impact, for papers by Matthias Zehner Breakdown of academic impact, for papers by Maria T. Arévalo Breakdown of academic impact, for papers by Nino Rcheulishvili
Rankless by CCL
2026